查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1946064

全球疫苗递送创新市场：预测（至2034年）－按疫苗类型、给药途径、技术、应用、最终用户和地区进行分析

Vaccine Delivery Innovations Market Forecasts to 2034 - Global Analysis By Vaccine Type, Route of Administration, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的研究，预计到 2026 年，全球疫苗输送创新市场将达到 85.9 亿美元，在预测期内以 8.3% 的复合年增长率增长，到 2034 年将达到 162.7 亿美元。

疫苗递送创新是指旨在改善疫苗接种方式、提高疫苗效力、安全性和可近性的先进技术和方法。这些创新包括无针注射器、微针贴片、奈米颗粒平台、口服、鼻腔和肺部给药系统，以及植入式和经皮装置。透过提高患者依从性、减少疼痛和针刺伤，并实现标靶化或剂量优化给药，这些解决方案能够优化免疫接种效果。疫苗递送创新在支持常规免疫接种计划、应对疫情和临床研究以及扩大全球安全有效疫苗的可及性方面发挥着至关重要的作用。

全球免疫计划的扩展

全球疫苗递送创新市场正受到全球免疫规划扩展的显着推动。各国政府和卫生组织正日益积极地实施疫苗接种倡议，以预防感染疾病并改善公共卫生状况。这些计划需要安全且有效率的给药方案，以最大限度地提高疫苗接种率，尤其是在儿童和弱势群体中。采用包括无针和微针系统在内的先进技术，将有助于大规模免疫宣传活动，提高病患依从性，并加强全球疾病预防工作。

高昂的开发和设备成本

高昂的研发和设备成本是疫苗递送创新市场的主要阻碍因素。微针贴片、奈米颗粒平台和植入式系统等先进递送技术需要大量的研发投入、合规性要求和专门的生产流程。这些成本通常会反映在产品定价中，从而可能限制价格敏感地区和开发中国家的采用。因此，医疗机构可能继续依赖传统的注射方法，这可能会减缓创新递送方案的普及。

技术进步

科技进步为疫苗递送创新市场带来了巨大的成长机会。诸如无针注射器、微针贴片和奈米颗粒平台等新型解决方案，提高了安全性，减轻了疼痛，并增强了患者依从性。口服和肺部给药方式的创新拓展了给药途径，并实现了标靶给药和剂量优化。在这些领域持续进行研发，有助于提高疫苗接种率，支持临床试验，并增强应对突发公共卫生事件的能力，从而使技术成为未来市场成长的关键驱动力。

物流和基础设施挑战

物流和基础设施的挑战对疫苗递送创新技术的应用构成威胁。先进的管理系统通常需要专门的储存设施、低温运输管理和训练有素的人员，这在偏远或资源匮乏地区难以维持。配送的复杂性、医疗基础设施的差异以及供应链中断都可能导致疫苗接种计划的延误，并降低创新技术的应用。克服这些障碍对于确保有效的免疫宣传活动以及在全球范围内最大限度地发挥疫苗递送创新技术的潜力至关重要。

新冠疫情的影响：

新冠疫情对疫苗递送创新市场产生了双重影响。一方面，供应链和常规免疫接种计划一度中断；另一方面，疫情加速了mRNA疫苗、无针注射器和微针贴片等先进递送技术的研发和应用。大众对疫苗安全性和免疫接种重要性的认识不断提高，也推动了对创新给药方式的需求。疫情后，对疫情应对、强化分销基础设施和居家免疫接种倡议的投资预计将进一步促进市场成长。

在预测期内，皮下给药领域预计将占据最大的市场份额。

由于皮下注射的广泛应用及其在多种疫苗接种方面的灵活性，预计在预测期内，皮下注射仍将占据最大的市场份额。皮下注射因其能够精准给药并减少全身副作用，是儿童疫苗、常规免疫接种计画和某些治疗性疫苗的首选给药方式。医疗机构和医护人员也因其安全性、可靠性和易用性而支持这种方法。因此，在传统和创新疫苗接种途径中，皮下注射继续占据市场主导地位。

预计在预测期内，儿童疫苗领域将呈现最高的复合年增长率。

在预测期内，由于全球婴幼儿免疫接种活动的扩大，儿童疫苗领域预计将呈现最高的成长率。政府免疫接种计划和创新给药技术的普及正在推动疫苗的推广应用。无针注射器、微针贴片和口服疫苗透过减少传统注射带来的疼痛和恐惧，提高了儿童的接种依从性。公共卫生重视程度的提高和技术应用的协同效应，使儿童疫苗成为疫苗给药创新市场中成长最快的细分领域。

市占率最大的地区：

在预测期内，北美预计将保持最大的市场份额，这主要得益于其对先进疫苗输送技术的高采用率以及政府和私营部门在免疫规划方面的大量投资。主要市场参与者的存在、积极的研发活动以及对无针注射器、微针贴片和奈米颗粒平台等创新技术的早期应用，都巩固了该地区的市场主导地位。此外，人们对疫苗安全性和常规免疫规划的高度重视也持续推动了对创新疫苗传递解决方案的强劲需求。

复合年增长率最高的地区：

在预测期内，亚太地区预计将呈现最高的复合年增长率，这主要得益于人口增长、医疗保健支出增加以及免疫意识的提高。政府资助的疫苗接种计划的扩大、医疗基础设施的改善以及微针贴片、口服疫苗和无针系统等先进递送技术的应用，都推动了该地区的快速成长。随着中国、印度和东南亚等新兴市场的疫苗供应和分发力度加强，亚太地区已成为疫苗递送创新领域成长最快的地区。

免费客製化服务：

订阅本报告的用户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他公司（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣量身定制的主要国家/地区的市场估算、预测和复合年增长率（註：基于可行性检查）
  • 竞争性标竿分析
    • 根据产品系列、地理覆盖范围和策略联盟对主要企业进行基准分析。

目录

第一章执行摘要

  • 市场概览及主要亮点
  • 成长要素、挑战与机会
  • 竞争格局概述
  • 战略洞察与建议

第二章：研究框架

  • 研究目标和范围
  • 相关人员分析
  • 研究假设和限制
  • 调查方法

第三章 市场动态与趋势分析

  • 市场定义与结构
  • 主要市场驱动因素
  • 市场限制与挑战
  • 投资成长机会和重点领域
  • 产业威胁与风险评估
  • 科技与创新趋势
  • 新兴市场和高成长市场
  • 监管和政策环境
  • 新冠疫情的影响及復苏前景

第四章：竞争环境与策略评估

  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争公司之间的竞争
  • 主要企业市占率分析
  • 产品基准评效和效能比较

第五章：全球疫苗递送创新市场：依疫苗类型划分

  • 感染疾病疫苗
  • 药效疫苗
  • 病毒载体疫苗
  • 癌症免疫疗法疫苗
  • 儿童疫苗
  • 其他疫苗类型

第六章：全球疫苗递送创新市场：依给药途径划分

  • 肌肉内部
  • 皮内注射
  • 皮下
  • 口服
  • 鼻内
  • 肺内

第七章：全球疫苗递送创新市场：依技术划分

  • 传统注射系统
  • 无针注射器
  • 微针贴片系统
  • 基于奈米颗粒的递送平台
  • 口服疫苗
  • 鼻腔和肺部给药
  • 经皮疫苗递送
  • 嵌入式交付系统

第八章：全球疫苗递送创新市场：依应用领域划分

  • 常规免疫接种计划
  • 大流行病/疫情应对
  • 旅行者和成人的疫苗接种
  • 动物疫苗接种
  • 临床研究和试验

第九章：全球疫苗递送创新市场：依最终用户划分

  • 医院和诊所
  • 疫苗接种中心
  • 社区健康计划
  • 研究机构和学术机构
  • 製药和生物技术公司

第十章：全球疫苗递送创新市场：按地区划分

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 比利时
    • 瑞典
    • 瑞士
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 马来西亚
    • 新加坡
    • 越南
    • 其他亚太地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 南美洲其他地区
  • 世界其他地区（RoW）
    • 中东
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 以色列
      • 其他中东国家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲国家

第十一章 策略市场资讯

  • 产业加值网络与供应链评估
  • 空白区域和机会地图
  • 产品演进与市场生命週期分析
  • 通路、经销商和打入市场策略的评估

第十二章 产业趋势与策略倡议

  • 企业合併（M&A）
  • 伙伴关係、联盟和合资企业
  • 新产品发布和认证
  • 扩大生产能力和投资
  • 其他策略倡议

第十三章：公司简介

  • Becton, Dickinson and Company
  • Terumo Corporation
  • Nipro Corporation
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG
  • SCHOTT AG
  • PharmaJet, Inc.
  • Vaxxas Pty Ltd
  • Micron Biomedical, Inc.
  • AptarGroup, Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Sanofi SA
  • Moderna, Inc.
  • BioNTech SE
Product Code: SMRC33838

According to Stratistics MRC, the Global Vaccine Delivery Innovations Market is accounted for $8.59 billion in 2026 and is expected to reach $16.27 billion by 2034 growing at a CAGR of 8.3% during the forecast period. Vaccine delivery innovations refer to advanced technologies and methods designed to improve the administration, efficacy, safety, and accessibility of vaccines. These innovations include needle-free injectors, micro needle patches, nanoparticles based platforms, oral, intranasal, and pulmonary delivery systems, as well as implantable and Transdermal devices. By enhancing patient compliance, reducing pain and needle stick injuries, and enabling targeted or dose-sparing delivery, these solutions optimize immunization outcomes. Vaccine delivery innovations play a crucial role in supporting routine immunization programs, pandemic responses, and clinical research, while expanding access to safe and effective vaccines globally.

Market Dynamics:

Driver:

Expansion of Global Immunization Programs

The global vaccine delivery innovations market is being significantly driven by the expansion of immunization programs worldwide. Governments and health organizations are increasingly implementing vaccination initiatives to prevent infectious diseases and improve public health outcomes. These programs demand safe and efficient delivery solutions to maximize coverage, especially in children and vulnerable populations. Adoption of advanced technologies, including needle-free and micro-needle systems, supports mass immunization campaigns, enhances patient compliance, and strengthens global efforts toward disease prevention.

Restraint:

High Development and Device Costs

High development and device costs are a key restraint for the vaccine delivery innovations market. Advanced delivery technologies such as micro needle patches, nanoparticles platforms, and implantable systems require substantial research, regulatory compliance, and specialized manufacturing processes. These costs are often reflected in product pricing, which can limit adoption in price sensitive regions or developing countries. As a result, healthcare providers may continue relying on conventional injection methods, slowing the uptake of innovative delivery solutions.

Opportunity:

Technological Advancements

Technological advancements present a significant growth opportunity for the vaccine delivery innovations market. Emerging solutions, including needle free injectors, micro needle patches, and nanoparticles based platforms, improve safety, reduce pain, and enhance patient compliance. Innovations in oral and pulmonary delivery expand administration options and enable targeted, dose-sparing approaches. Continued research and development in these areas open opportunities for expanding vaccine coverage, supporting clinical trials, and addressing public health emergencies, positioning technology as a key driver for future market growth.

Threat:

Logistical and Infrastructure Challenges

Logistical and infrastructure challenges pose a threat to the adoption of vaccine delivery innovations. Advanced delivery systems often require specialized storage, cold chain management, and trained personnel, which can be difficult to maintain in remote or resource-limited regions. Distribution complexities, inconsistent healthcare infrastructure, and supply chain disruptions may delay vaccination programs, reducing access to innovative technologies. Addressing these barriers is essential to ensure effective immunization campaigns and achieve the full potential of vaccine delivery innovations globally.

Covid-19 Impact:

The COVID-19 pandemic had a dual impact on the vaccine delivery innovations market. While supply chains and routine vaccination programs were temporarily disrupted, the crisis accelerated research, development, and adoption of advanced delivery technologies such as mRNA vaccines, needle free injectors, and micro needle patches. Increased public awareness of vaccine safety and immunization importance spurred demand for innovative delivery methods. Post-pandemic, investment in pandemic preparedness, enhanced distribution infrastructure, and home-based immunization initiatives are expected to further boost market growth.

The subcutaneous segment is expected to be the largest during the forecast period

The subcutaneous segment is expected to account for the largest market share during the forecast period, due to its widespread use and versatility in delivering a wide range of vaccines. Subcutaneous administration is preferred for pediatric vaccines, routine immunization programs, and certain therapeutic vaccines because it allows precise dosing and reduces systemic side effects. Healthcare providers and institutions favor this method for its safety, reliability, and familiarity. Consequently, subcutaneous delivery continues to dominate the market among conventional and innovative vaccine administration routes.

The pediatric vaccines segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pediatric vaccines segment is predicted to witness the highest growth rate, due to increasing vaccination initiatives for children and infants worldwide. Government immunization programs and growing access to innovative delivery technologies drive adoption. Needle free injectors, micro needle patches, and oral vaccines improve compliance in children by reducing pain and fear associated with traditional injections. The combination of public health focus and technological adoption positions pediatric vaccines as the fastest-growing segment in the vaccine delivery innovations market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high adoption of advanced vaccine delivery technologies, and significant government and private investment in immunization programs. The presence of key market players, robust R&D activities, and early adoption of innovations such as needle free injectors, micro needle patches, and nanoparticles based platforms support market dominance. Additionally, high awareness of vaccine safety and routine immunization programs sustains strong demand for innovative delivery solutions in the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to increasing population, growing healthcare expenditure, and rising awareness of immunization. Expansion of government funded vaccination programs, improved healthcare infrastructure, and adoption of advanced delivery technologies such as micro needle patches, oral vaccines, and needle free systems are driving rapid growth. Emerging markets including China, India, and Southeast Asia are witnessing increased vaccine accessibility and distribution initiatives, making Asia Pacific the fastest growing region for vaccine delivery innovations.

Key players in the market

Some of the key players in Vaccine Delivery Innovations Market include Becton, Dickinson and Company, Terumo Corporation, Nipro Corporation, West Pharmaceutical Services, Inc., Gerresheimer AG, SCHOTT AG, PharmaJet, Inc., Vaxxas Pty Ltd, Micron Biomedical, Inc., AptarGroup, Inc., Pfizer Inc., GlaxoSmithKline plc, Sanofi S.A., Moderna, Inc. and BioNTech SE

Key Developments:

In January 2026, Pfizer and Cartography Biosciences forged a multi-year collaboration to use Cartography's ATLAS and SUMMIT discovery platforms to pinpoint tumor-selective antigens for future cancer therapies, with Pfizer funding research and holding development and commercialization rights.

In December 2025, Pfizer struck an exclusive global collaboration and license deal with YaoPharma to develop, manufacture, and commercialize YP05002, an oral GLP 1 weight management agent, advancing its cardiometabolic pipeline with upfront and milestone payments and potential worldwide impact.

Vaccine Types Covered:

  • Infectious Disease Vaccines
  • mRNA Vaccines
  • Viral Vector Vaccines
  • Cancer Immunotherapy Vaccines
  • Pediatric Vaccines
  • Other Vaccine Types

Route of Administrations Covered:

  • Intramuscular
  • Intradermal
  • Subcutaneous
  • Oral
  • Nasal
  • Pulmonary

Technologies Covered:

  • Traditional Injectable Systems
  • Needle-Free Injectors
  • Microneedle Patch Systems
  • Nanoparticle-Based Delivery Platforms
  • Oral Vaccine Delivery
  • Intranasal & Pulmonary Delivery
  • Transdermal Vaccine Delivery
  • Implantable Delivery Systems

Applications Covered:

  • Routine Immunization Programs
  • Pandemic/Epidemic Response
  • Travel & Adult Immunization
  • Veterinary Vaccine Delivery
  • Clinical Research & Trials

End Users Covered:

  • Hospitals & Clinics
  • Vaccination Centers
  • Community Health Programs
  • Research Institutes & Academia
  • Pharmaceutical & Biotech Firms

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Vaccine Delivery Innovations Market, By Vaccine Type

  • 5.1 Infectious Disease Vaccines
  • 5.2 mRNA Vaccines
  • 5.3 Viral Vector Vaccines
  • 5.4 Cancer Immunotherapy Vaccines
  • 5.5 Pediatric Vaccines
  • 5.6 Other Vaccine Types

6 Global Vaccine Delivery Innovations Market, By Route of Administration

  • 6.1 Intramuscular
  • 6.2 Intradermal
  • 6.3 Subcutaneous
  • 6.4 Oral
  • 6.5 Nasal
  • 6.6 Pulmonary

7 Global Vaccine Delivery Innovations Market, By Technology

  • 7.1 Traditional Injectable Systems
  • 7.2 Needle Free Injectors
  • 7.3 Microneedle Patch Systems
  • 7.4 Nanoparticle Based Delivery Platforms
  • 7.5 Oral Vaccine Delivery
  • 7.6 Intranasal & Pulmonary Delivery
  • 7.7 Transdermal Vaccine Delivery
  • 7.8 Implantable Delivery Systems

8 Global Vaccine Delivery Innovations Market, By Application

  • 8.1 Routine Immunization Programs
  • 8.2 Pandemic/Epidemic Response
  • 8.3 Travel & Adult Immunization
  • 8.4 Veterinary Vaccine Delivery
  • 8.5 Clinical Research & Trials

9 Global Vaccine Delivery Innovations Market, By End User

  • 9.1 Hospitals & Clinics
  • 9.2 Vaccination Centers
  • 9.3 Community Health Programs
  • 9.4 Research Institutes & Academia
  • 9.5 Pharmaceutical & Biotech Firms

10 Global Vaccine Delivery Innovations Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Becton, Dickinson and Company
  • 13.2 Terumo Corporation
  • 13.3 Nipro Corporation
  • 13.4 West Pharmaceutical Services, Inc.
  • 13.5 Gerresheimer AG
  • 13.6 SCHOTT AG
  • 13.7 PharmaJet, Inc.
  • 13.8 Vaxxas Pty Ltd
  • 13.9 Micron Biomedical, Inc.
  • 13.10 AptarGroup, Inc.
  • 13.11 Pfizer Inc.
  • 13.12 GlaxoSmithKline plc
  • 13.13 Sanofi S.A.
  • 13.14 Moderna, Inc.
  • 13.15 BioNTech SE

List of Tables

  • Table 1 Global Vaccine Delivery Innovations Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Vaccine Delivery Innovations Market Outlook, By Vaccine Type (2023-2034) ($MN)
  • Table 3 Global Vaccine Delivery Innovations Market Outlook, By Infectious Disease Vaccines (2023-2034) ($MN)
  • Table 4 Global Vaccine Delivery Innovations Market Outlook, By mRNA Vaccines (2023-2034) ($MN)
  • Table 5 Global Vaccine Delivery Innovations Market Outlook, By Viral Vector Vaccines (2023-2034) ($MN)
  • Table 6 Global Vaccine Delivery Innovations Market Outlook, By Cancer Immunotherapy Vaccines (2023-2034) ($MN)
  • Table 7 Global Vaccine Delivery Innovations Market Outlook, By Pediatric Vaccines (2023-2034) ($MN)
  • Table 8 Global Vaccine Delivery Innovations Market Outlook, By Other Vaccine Types (2023-2034) ($MN)
  • Table 9 Global Vaccine Delivery Innovations Market Outlook, By Route of Administration (2023-2034) ($MN)
  • Table 10 Global Vaccine Delivery Innovations Market Outlook, By Intramuscular (2023-2034) ($MN)
  • Table 11 Global Vaccine Delivery Innovations Market Outlook, By Intradermal (2023-2034) ($MN)
  • Table 12 Global Vaccine Delivery Innovations Market Outlook, By Subcutaneous (2023-2034) ($MN)
  • Table 13 Global Vaccine Delivery Innovations Market Outlook, By Oral (2023-2034) ($MN)
  • Table 14 Global Vaccine Delivery Innovations Market Outlook, By Nasal (2023-2034) ($MN)
  • Table 15 Global Vaccine Delivery Innovations Market Outlook, By Pulmonary (2023-2034) ($MN)
  • Table 16 Global Vaccine Delivery Innovations Market Outlook, By Technology (2023-2034) ($MN)
  • Table 17 Global Vaccine Delivery Innovations Market Outlook, By Traditional Injectable Systems (2023-2034) ($MN)
  • Table 18 Global Vaccine Delivery Innovations Market Outlook, By Needle Free Injectors (2023-2034) ($MN)
  • Table 19 Global Vaccine Delivery Innovations Market Outlook, By Microneedle Patch Systems (2023-2034) ($MN)
  • Table 20 Global Vaccine Delivery Innovations Market Outlook, By Nanoparticle Based Delivery Platforms (2023-2034) ($MN)
  • Table 21 Global Vaccine Delivery Innovations Market Outlook, By Oral Vaccine Delivery (2023-2034) ($MN)
  • Table 22 Global Vaccine Delivery Innovations Market Outlook, By Intranasal & Pulmonary Delivery (2023-2034) ($MN)
  • Table 23 Global Vaccine Delivery Innovations Market Outlook, By Transdermal Vaccine Delivery (2023-2034) ($MN)
  • Table 24 Global Vaccine Delivery Innovations Market Outlook, By Implantable Delivery Systems (2023-2034) ($MN)
  • Table 25 Global Vaccine Delivery Innovations Market Outlook, By Application (2023-2034) ($MN)
  • Table 26 Global Vaccine Delivery Innovations Market Outlook, By Routine Immunization Programs (2023-2034) ($MN)
  • Table 27 Global Vaccine Delivery Innovations Market Outlook, By Pandemic/Epidemic Response (2023-2034) ($MN)
  • Table 28 Global Vaccine Delivery Innovations Market Outlook, By Travel & Adult Immunization (2023-2034) ($MN)
  • Table 29 Global Vaccine Delivery Innovations Market Outlook, By Veterinary Vaccine Delivery (2023-2034) ($MN)
  • Table 30 Global Vaccine Delivery Innovations Market Outlook, By Clinical Research & Trials (2023-2034) ($MN)
  • Table 31 Global Vaccine Delivery Innovations Market Outlook, By End User (2023-2034) ($MN)
  • Table 32 Global Vaccine Delivery Innovations Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 33 Global Vaccine Delivery Innovations Market Outlook, By Vaccination Centers (2023-2034) ($MN)
  • Table 34 Global Vaccine Delivery Innovations Market Outlook, By Community Health Programs (2023-2034) ($MN)
  • Table 35 Global Vaccine Delivery Innovations Market Outlook, By Research Institutes & Academia (2023-2034) ($MN)
  • Table 36 Global Vaccine Delivery Innovations Market Outlook, By Pharmaceutical & Biotech Firms (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.